Shares of Diaceutics PLC (LON:DXRX - Get Free Report) traded up 0.4% on Tuesday . The company traded as high as GBX 120 ($1.59) and last traded at GBX 118 ($1.57). 23,993 shares traded hands during trading, a decline of 76% from the average session volume of 99,987 shares. The stock had previously closed at GBX 117.50 ($1.56).
Diaceutics Trading Down 0.7 %
The company has a market cap of £102.20 million, a PE ratio of -35.92 and a beta of 0.58. The stock has a 50 day moving average price of GBX 123.41 and a 200 day moving average price of GBX 127.29. The company has a current ratio of 4.85, a quick ratio of 9.92 and a debt-to-equity ratio of 0.39.
Diaceutics Company Profile
(
Get Free Report)
At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network®.
Read More
Before you consider Diaceutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diaceutics wasn't on the list.
While Diaceutics currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
